Articles tagged "Hepatocellular carcinoma"

2015 American Transplant Congress
Associations Between Sirolimus Use and Outcomes After Liver Transplant for Hepatocellular Carcinoma
E. Yanik,¹ S. Chinnakotla,² A. Israni,^2,3 J. Snyder,^2,3 S. Gustafson,³ E. Engels.¹
¹Natl. Cancer Inst., Bethesda, MD; ²U. of Minnesota, Minneapolis, MN; ³Sci. Reg. of Transplant Recipients, Minneapolis, MN.
A growing fraction of U.S. liver transplants are being done for the indication of hepatocellular carcinoma (HCC). HCC recurrence after transplant remains a major concern…
2015 American Transplant Congress
Pretransplant Elevated Plasma Fibrinogen Level Is Associated With Tumor Recurrence and Poor Prognosis in Hepatocellular Carcinoma Patients After Liver Transplantation
G.-Y. Wang, Y. Yang, H. Li, S.-H. Yi, G.-H. Chen.
Department of Hepatic Surgery and Liver Transplant Center, Third Affiliated Hospital, Sun Yat-sen University, Organ Transplantation Institution of Sun Yat-sen University, Guangzhou, China.
Background and Objective: Elevated plasma fibrinogen (FBG) level is associated with tumor progression and poor patient outcomes in several cancers. The aim of this study…
2015 American Transplant Congress
Impact of Everolimus On the Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation When Used in Early Stage: A Single Center Prospective Study
L. Jeng, A. Thorat, H. Yang, C.-C. Yeh, T.-H. Chen, S.-C. Hsu.
Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan.
Background:Liver transplantation is only treatment for unresectable hepatocellular carcinoma (HCC). However, postoperative immunosuppression may act as an additional risk factor for tumour recurrence. Antineoplastic role…